Literature DB >> 6697567

Inhibition of autoimmune hepatitis with hot labelled liver specific antigen.

J Fehér, G Filipp, L Kocsár, K Mohari, H Toncsev, E Fehér, G Biro.   

Abstract

In accordance with the clonal selection theory the authors intended to prevent the development of autoimmune hepatitis in rabbits with the aid of radiolabelled liver specific membrane (LSP) antigen administered prior to the antigen immunization. The autoimmune hepatitis was produced in rabbits by allogen LSP antigen. The inflammatory reaction was characterized by the serum glutamic oxaloacetic transaminase activity in the sera, by the parameters of immune reaction as well as by lysosomal membrane alterations in the liver and by morphological findings. The process was inhibited by pre-treatment with hot labelled LSP antigen. Neither the radioactively labelled growth hormone pre-treatment, nor the application of hot labelled antigen at the last week of the experiment were able to prevent the humoral and lysosomal, as well as the morphological data characteristic for autoimmune hepatitis. The results obtained may be understood considering the mechanism of clonal selection.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6697567      PMCID: PMC1535828     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  10 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Studies on "liver-specific" antigens. I. Evaluation of the liver specificity of "LSP" and "LP-2".

Authors:  U J Behrens; F Paronetto
Journal:  Gastroenterology       Date:  1979-11       Impact factor: 22.682

3.  Studies on "liver-specific" antigens. II. Detection of serum antibodies to liver and kidney cell membrane antigens in patients with chronic liver disease.

Authors:  U J Behrens; S Vernace; F Paronetto
Journal:  Gastroenterology       Date:  1979-11       Impact factor: 22.682

4.  Experimental chronic active hepatitis in rabbits following immunization with human liver proteins.

Authors:  K H Büschenfelde; F K Kössling; P A Miescher
Journal:  Clin Exp Immunol       Date:  1972-05       Impact factor: 4.330

5.  Studies on the pathogenesis of experimental chronic active hepatitis in rabbits. I. Induction of the disease and protective effect of allogeneic liver specific proteins.

Authors:  K H Meyer zum Büschenfelde; U Hopf
Journal:  Br J Exp Pathol       Date:  1974-10

6.  Selective suppression of antibody production with the aid of radiolabelled birch pollen allergen.

Authors:  G Filipp; G Biró; W D Hartung; G Lehmann
Journal:  Allergy       Date:  1981-05       Impact factor: 13.146

7.  Purification and characterization of human liver-specific membrane lipoprotein (LSP).

Authors:  I G McFarlane; B M Wojcicka; G M Zucker; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1977-03       Impact factor: 4.330

8.  Simple method of circulating immune complex detection in human sera by polyethylene glycol precipitation.

Authors:  V Hasková; J Kaslík; I Ríha; I Matl; J Rovenský
Journal:  Z Immunitatsforsch Immunobiol       Date:  1978-06

9.  Lysosomal enzymes in sera and granulocytes of patients with chronic liver diseases.

Authors:  J Fehér; H Toncsev; E Fehér; A Kiss; A Vasady
Journal:  Int J Tissue React       Date:  1981-03

10.  Immunological reactions to liver-specific membrane lipoprotein (LSP) in experimental autoimmune liver disease in rabbits.

Authors:  R M Uibo; H J Helin; K J Krohn
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

  10 in total
  1 in total

Review 1.  Treatment of B-cell lymphoma using peptides. A novel concept.

Authors:  K S Lam
Journal:  West J Med       Date:  1993-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.